All News

Pharmacists and interns who prepare HDs or work in areas where these drugs are located are potentially at risk for these adverse health effects. It is important for us to understand the risks and be proactive about protecting ourselves.

With a cohort of approximately 50,000, this may be the largest exome sequencing study of type 2 diabetes.

Although recent trials for Merck's pembrolizumab injection demonstrated promise for recurrent or metastatic head and neck squamous cell carcinoma, testing for patients with metastatic triple-negative breast cancer did not meet the primary endpoint.

The survey looked into the participants’ confidence of specific approaches, including outcome-related measures, fee-for-service, intermediate outcome, and outcome-related measures.

The CDC has indicated that many recent measles cases reported in the United States in 2018 have been the result of international travel to areas of the world where the virus is active, and individuals who are not vaccinated against the virus.

Valoctocogene roxaparvovec (BioMarin) met pre-specified criteria for Factor VIII activity levels treating severe hemophilia A in a phase 3 clinical trial.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The agency has opened a public docket to solicit feedback on the proposed requirement, which would necessitate certain immediate-release opioid analgesics be made available in fixed-quantity, unite-of-use blister packaging.

As more novel therapies emerge from the pipeline and enter the market, it is crucial for pharmacists to monitor new drug approvals that could be lifechanging for their patients.

Gilteritinib (Xospata, Astellas Pharma) is indicated for adults with relapsed/refractory acute myeloid leukemia with an FMS-like tyrosine kinase 3 mutation.

Gilteritinib (Xospata, Astellas Pharma) is indicated for adults with relapsed/refractory acute myeloid leukemia with an FMS-like tyrosine kinase 3 mutation.

Patients must be counseled about the risk of acute or chronic liver steatosis associated with all prescription and over the counter medications.

Top news of the day from across the health care landscape.

You know what DNA is, but do you really know what leadership is?

A ‘fail-first’ policy by the Centers for Medicare and Medicaid Services could be a nightmare for patients with cancer, according to the Community Oncology Alliance.

The importance of improving the specialty pharmacy experience for patients newly diagnosed with a life-changing disease.

The oral tablets under review by the FDA should be paired with rest, physical therapy and other measures, according to manufacturer Galt Pharmaceuticals.

The online program trains health care professionals in fundamentals of enteral and parenteral nutrition.

Many patients with pancreatic cancer do not receive cancer-directed treatment that may extend survival.

Top news of the day from across the health care landscape.

The approval of R2 is based on data from the phase 3 AUGMENT study evaluating the safety and efficacy of the combination regimen compared with rituximab plus placebo in patients with previously-treated FL and MZL.

Effective treatment with ART has increased the life span of people living with HIV, but they remain at risk for chronic diseases.

Officials with the FDA today approved lenalidomide (Revlimid, Celgene) in combination with a rituximab product (R2) for the treatment of adult patients with previously-treated follicular lymphoma or marginal zone lymphoma.

The new indication makes cariprazine the first and only dopamine and serotonin partial agonist to treat the full spectrum of bipolar I symptoms in manic, mixed, and depressive episodes.

The new indication makes cariprazine (Vraylar, Allergan and Gedeon Richter) the first and only dopamine and serotonin partial agonist to treat the full spectrum of bipolar I symptoms in manic, mixed, and depressive episodes, according to the companies.

The PHARM-CHF trial investigated whether regularly seeing a pharmacist improves adherence to heart failure medications.

Uncontrolled diabetes in pregnancy can lead to preeclampsia, cesarean delivery, preterm delivery, significant overgrowth in the child, and congenital defects.

Genomic data may improve the selection of more precise models for metastatic breast cancer research.

Top news of the day from across the health care landscape.